ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 275 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2024. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,751,726 | -9.1% | 67,400 | 0.0% | 2.27% | +59.5% |
| Q1 2024 | $1,927,640 | -6.5% | 67,400 | 0.0% | 1.42% | -16.7% |
| Q4 2023 | $2,062,440 | +13.9% | 67,400 | 0.0% | 1.71% | -17.7% |
| Q3 2023 | $1,811,038 | -24.6% | 67,400 | 0.0% | 2.08% | -34.6% |
| Q2 2023 | $2,403,484 | +40.4% | 67,400 | 0.0% | 3.18% | +64.0% |
| Q1 2023 | $1,711,960 | -70.7% | 67,400 | -53.2% | 1.94% | -65.2% |
| Q4 2022 | $5,836,584 | – | 143,900 | – | 5.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |